LENZ Therapeutics (LENZ) Is Down 7.1% After VIZZ Middle East Deal And Early Launch Data - Has The Bull Case Changed? [Yahoo! Finance]
LENZ Therapeutics, Inc. (LENZ)
Company Research
Source: Yahoo! Finance
FDA-approved aceclidine-based eye drop for presbyopia, across key Middle Eastern markets including the UAE, Saudi Arabia, and Qatar. This deal, alongside early US launch data showing around US$1.6 million in Q4 2025 VIZZ revenue and more than 20,000 prescriptions, highlights LENZ's push to turn its presbyopia franchise into a global business. We'll now examine how this early VIZZ uptake, combined with the new Middle East distribution agreement, shapes LENZ Therapeutics' investment narrative. AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early. For LENZ Therapeutics, the core belief is that VIZZ can become a meaningful commercial franchise in presbyopia, with the U.S. launch as the centerpiece and ex-US partnerships helping to fund the journey. The early Q4 2025 VIZZ numbers, while still small at around US$1.6 million in r
Show less
Read more
Impact Snapshot
Event Time:
LENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LENZ alerts
High impacting LENZ Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LENZ
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZPR Newswire
- LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign [Yahoo! Finance]Yahoo! Finance
- LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaignPR Newswire
- LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaignGlobeNewswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZGlobeNewswire
LENZ
Earnings
- 11/5/25 - Beat
LENZ
Sec Filings
- 1/7/26 - Form 8-K
- 1/6/26 - Form 4
- 1/6/26 - Form 4
- LENZ's page on the SEC website